¹øÈ£ | Á¦¸ñ | ÀÛ¼ºÀÏ | ÷ºÎ | Á¶È¸ |
* |
ÁÖ¿ä ¹é½Å ÀÓ»ó ³í¹®µé(Updated at 2020.1.29) |
2021-02-02 |
|
1900 |
5 |
Moderna 1Â÷ Á¢Á¾ ÈÄ ¹ß»ýÇÑ Allergic Reactions ¿¡ ´ëÇÑ ¹Ì±¹ CDC ¹ßÇ¥ ÀÚ·á |
2021-02-16 |
|
1163 |
4 |
ÁÖ¿ä ¹é½Å ÀÓ»ó ³í¹®µé_2020.12.17 |
2020-12-17 |
|
5760 |
3 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020) |
2020-11-30 |
|
896 |
2 |
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (The Lancet Infectious Disease, Published: November 17, 2020) |
2020-11-30 |
|
660 |
1 |
¿¹¹æ ¹× ¹é½Å review article (systemic review, meta analysis Æ÷ÇÔ) |
2020-11-19 |
|
1415 |